rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    SGHT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids
      Nov 5Yahoo FinanceSGHT
      Sight Sciences Inc (SGHT) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised Guidance, ...

      Sight Sciences Inc (SGHT) posts record $24.9 million in Q3 revenue, lifts full-year 2026 guidance to $92--$93 million, and scales its IDE business with 222 ordering accounts.

      Nov 5Yahoo FinanceSGHT
      What Sight Sciences (SGHT) Said on Its Q3 Earnings Call
      Nov 5Yahoo FinanceSGHT
      Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

      While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

      Nov 5Yahoo FinanceSGHT
      Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates

      Sight Sciences (SGHT) delivered earnings and revenue surprises of 0.00% and +6.46%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

      Nov 4Yahoo FinanceSGHT
      Sight Sciences Q3 2026 Earnings Call Transcript
      Nov 4BenzingaSGHT
      Sight Sciences Reports Third Quarter 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance
      Nov 4Yahoo FinanceSGHT
      Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
      Nov 4Yahoo FinanceSGHT
      Earnings to Watch: Sight Sciences Inc (SGHT) Q3 2026 -- GF Value Sees 41% Downside
      Nov 3Yahoo FinanceSGHT
      Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

      MENLO PARK, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced it will report financial results for the third quarter ended September 30, 2026, after the market close on Wednesday, November 4, 2026. The Company’s management will discuss the results during

      Oct 21Yahoo FinanceSGHT
      Why Is Sight Sciences Stock Gaining Thursday?
      Oct 15BenzingaSGHT
      HC Wainwright Initiates Coverage on Sight Sciences With Buy Rating, $14 Price Target
      Oct 15Yahoo FinanceSGHT
      Sight Sciences COO Alison Bauerlein sells $223,626 in stock
      Oct 12Investing.comSGHT
      Sight sciences CFO Rodberg sells $63,812 in shares
      Oct 12Investing.comSGHT
      Sight Sciences director and CTO David Badawi sells $70,555 in stock
      Oct 12Investing.comSGHT
      Sight Sciences CEO Paul Badawi sells $268,329 in stock
      Oct 12Investing.comSGHT
      Sight Sciences: Signs Of Progress, But Plenty Of Work Remains (NASDAQ:SGHT)

      Sight Sciences is a cautious 'buy,' as recent reimbursement wins and product momentum support a positive outlook. Click to read more on the SGHT.

      Oct 9Seeking AlphaSGHT
      Sight Sciences (SGHT) Stock Gets Fair Value Boost After Analyst Target Increases
      Oct 8Yahoo FinanceSGHT
      Sight Sciences launches OMNI Ultra surgical system for glaucoma
      Oct 1Investing.comSGHT
      Sight Sciences to Debut the OMNI Ultra® Surgical System, the Latest Technology Advancement from the Pioneers of Ab Interno Canaloplasty, at the 2026 American Academy of Ophthalmology (AAO) Annual Meeting

      MENLO PARK, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional technologies intended to transform eye care and improve patients’ lives, today announced the commercial availability of the OMNI® Ultra Surgical System (OMNI Ultra), an expansion of its pioneering ab interno canaloplasty platform. The new technology will be featured at this year’s Americ

      Oct 1Yahoo FinanceSGHT
      Sight Sciences at Morgan Stanley conference: growth returns across two platforms
      Sep 15Investing.comSGHTMS
      Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

      MENLO PARK, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients’ lives, today announced that it will present at the upcoming Morgan Stanley Global Healthcare Conference in New York, NY. Sight Sciences’ management is scheduled to present on Tuesday, September 15, 2026, at 6:15 am

      Sep 1Yahoo FinanceSGHT

      This is the newest page. Registered accounts read further back.